Production of congenital malformations using tissueantisera. 8. Effectiveness of reduced, alkylated and digested anti-kidney antibodies.
D000014:Abnormalities, Drug-Induced / Q000276:immunology*; D000478:Alkylation; D000818:Animals; D000937:Antigen-Antibody Reactions; D000941:Antigens / Q000032:analysis; D002498:Centrifugation; D055598:Chemical Phenomena; D002621:Chemistry; D003168:Complement Fixation Tests; D005260:Female; D005865:Gestational Age; D007106:Immune Sera; D007668:Kidney / Q000276:immunology; D010084:Oxidation-Reduction; D010434:Pepsin A; D011233:Precipitin Tests; D011247:Pregnancy; D051381:Rats; D012756:Sheep; D005719:gamma-Globulins / Q000008:administration & dosage
D000941:Antigens; D007106:Immune Sera; D005719:gamma-Globulins; D010434:Pepsin A